Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Int J Mol Sci
2021 Dec 21;231:. doi: 10.3390/ijms23010042.
Show Gene links
Show Anatomy links
High-Dose Benzodiazepines Positively Modulate GABAA Receptors via a Flumazenil-Insensitive Mechanism.
Wang N
,
Lian J
,
Cao Y
,
Muheyati A
,
Yuan S
,
Ma Y
,
Zhang S
,
Yu G
,
Su R
.
???displayArticle.abstract???
Benzodiazepines (BZDs) produce versatile pharmacological actions through positive modulation of GABAA receptors (GABAARs). A previous study has demonstrated that high concentrations of diazepam potentiate GABA currents on the α1β2γ2 and α1β2 GABAARs in a flumazenil-insensitive manner. In this study, the high-concentration effects of BZDs and their sensitivity to flumazenil were determined on synaptic (α1β2γ2, α2β2γ2, α5β2γ2) and extra-synaptic (α4β2δ) GABAARs using the voltage-clamp electrophysiology technique. The in vivo evaluation of flumazenil-insensitive BZD effects was conducted in mice via the loss of righting reflex (LORR) test. Diazepam induced biphasic potentiation on the α1β2γ2, α2β2γ2 and α5β2γ2 GABAARs, but did not affect the α4β2δ receptor. In contrast to the nanomolar component of potentiation, the second potentiation elicited by micromolar diazepam was insensitive to flumazenil. Midazolam, clonazepam, and lorazepam at 200 µM exhibited similar flumazenil-insensitive effects on the α1β2γ2, α2β2γ2 and α5β2γ2 receptors, whereas the potentiation induced by 200 µM zolpidem or triazolam was abolished by flumazenil. Both the GABAAR antagonist pentylenetetrazol and Fa173, a proposed transmembrane site antagonist, abolished the potentiation induced by 200 µM diazepam. Consistent with the in vitro results, flumazenil antagonized the zolpidem-induced LORR, but not that induced by diazepam or midazolam. Pentylenetetrazol and Fa173 antagonized the diazepam-induced LORR. These findings support the existence of non-classical BZD binding sites on certain GABAAR subtypes and indicate that the flumazenil-insensitive effects depend on the chemical structures of BZD ligands.
Figure 1. Diazepam modulated the α1β2γ2, α2β2γ2 and α5β2γ2 receptors in flumazenil-sensitive and flumazenil-insensitive manners. The concentration-response relationships of diazepam for modulating the α1β2γ2 (A), α2β2γ2 (B), α5β2γ2 (C), and α4β2δ (D) receptors were determined in the absence or presence of flumazenil. The GABA concentrations were 1, 0.1, 1, and 0.1 μM for α1β2γ2, α2β2γ2, α5β2γ2, and α4β2δ receptors, respectively. Representative current traces are shown on the top; data summary is shown on the bottom. Data represent mean ± SEM, n = 4–5.
Figure 2. Different BZD ligands exhibited distinct modulation of ternary GABAARs. Effects of lorazepam (LOR), clonazepam (CLO), midazolam (MID), zolpidem (ZOL) and triazolam (TRI) in potentiating the GABA-elicited currents were evaluated at low (10 μM) and high (200 μM) concentrations in the absence or presence of flumazenil (100 μM) on the α1β2γ2 (A), α2β2γ2 (B), α5β2γ2 (C) and α4β2δ (D) receptors. The dotted lines indicate the basal levels without drug treatment. Data represent mean ± SEM, n = 4, * p < 0.05, ** p < 0.01, vs control group, via t-test.
Figure 3. Pentylenetetrazol and Fa173 abolished the flumazenil-insensitive diazepam effects on ternary GABAARs. Effects of diazepam (DZP) in potentiating the GABA-elicited currents were evaluated at low (10 μM) and high (200 μM) concentrations in the absence or presence of pentylenetetrazol (PTZ, 100 μM) or Fa173 (100 μM) on the α1β2γ2 (A), α2β2γ2 (B) and α5β2γ2 (C) receptors. The dotted lines indicate the basal levels without drug treatment. Data represent mean ± SEM, n = 4, * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control group, via t-test.
Figure 4. Flumazenil antagonized LORR induced by zolpidem, but not by diazepam or midazolam. A series of doses of diazepam (DZP), midazolam (MID) and zolpidem (ZOL) were administered intraperitoneally, and percentage of LORR (A,D,G) and latency to and duration of LORR (B,E,H) were recorded. Flumazenil (FLU) was intravenously injected immediately before BZD administration, and its effects on LORR induced by 50 mg kg−1 diazepam, 100 mg kg−1 midazolam or 50 mg kg−1 zolpidem were evaluated (C,F,I). Data represent mean ± SEM, n = 9−10. Figure on top of each bar is the number of mice that lost the righting reflex over the total number of the mice tested. One-way ANOVA; * p < 0.05, ** p < 0.01 vs control group, according to post hoc analysis with Dunnett’s multiple comparison test.
Figure 5. Pentylenetetrazol and Fa173 antagonized diazepam-induced LORR. Pentylenetetrazol (PTZ, 20 mg kg−1, i.v.) or Fa173 (1.2 μmol/mouse, i.c.v.) was injected immediately before diazepam (DZP, 50 mg kg−1, i.p.) administration. The effect of pentylenetetrazol (A) or Fa173 (B) on latency to and duration of diazepam-induced LORR were recorded. Data represent mean ± SEM, n = 10. Figure on top of each bar is the number of mice that lost the righting reflex over the total number of the mice tested. * p < 0.05, ** p < 0.01, *** p < 0.001 vs control group, via t-test.
Akk,
Structural studies of the actions of anesthetic drugs on the γ-aminobutyric acid type A receptor.
2011, Pubmed
Akk,
Structural studies of the actions of anesthetic drugs on the γ-aminobutyric acid type A receptor.
2011,
Pubmed
Auta,
Imidazenil: an antagonist of the sedative but not the anticonvulsant action of diazepam.
2005,
Pubmed
Baird,
Delayed recovery from a sedative: correlation of the plasma levels of diazepam with clinical effects after oral and intravenous administration.
1972,
Pubmed
Baur,
Covalent modification of GABAA receptor isoforms by a diazepam analogue provides evidence for a novel benzodiazepine binding site that prevents modulation by these drugs.
2008,
Pubmed
,
Xenbase
Baur,
A GABA(A) receptor of defined subunit composition and positioning: concatenation of five subunits.
2006,
Pubmed
,
Xenbase
Bonetti,
Benzodiazepine antagonist Ro 15-1788: neurological and behavioral effects.
1982,
Pubmed
Cao,
Flumazenil-insensitive benzodiazepine binding sites in GABAA receptors contribute to benzodiazepine-induced immobility in zebrafish larvae.
2019,
Pubmed
Celik,
The effects of flumazenil on two way active avoidance and locomotor activity in diazepam-treated rats.
1999,
Pubmed
Che Has,
Zolpidem is a potent stoichiometry-selective modulator of α1β3 GABAA receptors: evidence of a novel benzodiazepine site in the α1-α1 interface.
2016,
Pubmed
,
Xenbase
Chua,
GABAA Receptors and the Diversity in their Structure and Pharmacology.
2017,
Pubmed
Drexler,
Diazepam decreases action potential firing of neocortical neurons via two distinct mechanisms.
2010,
Pubmed
Farrant,
Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors.
2005,
Pubmed
Fernandez,
Flavan-3-ol esters: new agents for exploring modulatory sites on GABA(A) receptors.
2012,
Pubmed
,
Xenbase
Gunja,
The clinical and forensic toxicology of Z-drugs.
2013,
Pubmed
Jacob,
GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition.
2008,
Pubmed
Kim,
Shared structural mechanisms of general anaesthetics and benzodiazepines.
2020,
Pubmed
Klockowski,
Kinetics of drug action in disease states. XXIV. Pharmacodynamics of diazepam and its active metabolites in rats.
1988,
Pubmed
Lian,
Flumazenil-Insensitive Benzodiazepine Effects in Recombinant αβ and Neuronal GABAA Receptors.
2020,
Pubmed
Maldifassi,
Novel positive allosteric modulators of GABAA receptors with anesthetic activity.
2016,
Pubmed
,
Xenbase
Masiulis,
GABAA receptor signalling mechanisms revealed by structural pharmacology.
2019,
Pubmed
McGrath,
Selective actions of benzodiazepines at the transmembrane anaesthetic binding sites of the GABAA receptor: In vitro and in vivo studies.
2021,
Pubmed
McGrath,
Competitive Antagonism of Etomidate Action by Diazepam: In Vitro GABAA Receptor and In Vivo Zebrafish Studies.
2020,
Pubmed
Middendorp,
Positive modulation of synaptic and extrasynaptic GABAA receptors by an antagonist of the high affinity benzodiazepine binding site.
2015,
Pubmed
,
Xenbase
Olsen,
GABAA receptor: Positive and negative allosteric modulators.
2018,
Pubmed
Ramerstorfer,
The GABAA receptor alpha+beta- interface: a novel target for subtype selective drugs.
2011,
Pubmed
,
Xenbase
Rudolph,
Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes.
2011,
Pubmed
Sieghart,
Subunit composition, distribution and function of GABA(A) receptor subtypes.
2002,
Pubmed
Sieghart,
Allosteric modulation of GABAA receptors via multiple drug-binding sites.
2015,
Pubmed
Sigel,
The Benzodiazepine Binding Sites of GABAA Receptors.
2018,
Pubmed
Walters,
Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms.
2000,
Pubmed
,
Xenbase
Wongsamitkul,
α subunits in GABAA receptors are dispensable for GABA and diazepam action.
2017,
Pubmed
,
Xenbase
Zhu,
Structure of a human synaptic GABAA receptor.
2018,
Pubmed
Zhuo,
The glycine hinge of transmembrane segment 2 modulates the subcellular localization and gating properties in TREK channels.
2017,
Pubmed
